Lipoprotein-associated phospholipase A2 activity predicts progression of subclinical coronary atherosclerosis.
Kinney GL, Snell-Bergeon JK, Maahs DM, Eckel RH, Ehrlich J, Rewers M, Hokanson JE. Lipoprotein-associated phospholipase A2 activity predicts progression of subclinical coronary atherosclerosis. Diabetes Technol Ther. 2011 Mar; 13(3):381-7.